Eli Lilly Acquires LimmaTech Biologics for Up to USD 780 Million

Homburger has advised Eli Lilly. LimmaTech is supported by Moelis & Company UK LLP as financial advisor and Goodwin Procter and VISCHER as legal advisors. On…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here